Advisory committees nominations
This article was originally published in The Tan Sheet
Any firms interested in nominating industry representatives to serve on the Center for Drug Evaluation and Research's public advisory committees must notify FDA by July 9, the agency says. FDA announces in the Federal Register June 8 industry representatives may serve as nonvoting members on public advisory committees such as the Nonprescription Drugs Advisory Committee and the Advisory Committee for Reproductive Health Drugs...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.